MedPath
HSA Approval

CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL

SIN14658P

CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL

CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL

November 6, 2014

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DE01

cefepime

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

QILU PHARMACEUTICAL CO., LTD

QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD (Blend-Cefepime Hydrochloride (Contains Arginine))

Active Ingredients

CEFEPIME HYDROCHLORIDE 1189 mg EQV CEFEPIME BASE

1000MG

Cefepime

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL - HSA Approval | MedPath